Real-time enrollment status for this mild cognitive impairment clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:59 PM UTC
| NCT Number | NCT05016219 |
| Recruiting Status | Recruiting |
| Condition | Mild Cognitive Impairment |
| Phase | Clinical Trial |
| Target Enrollment | 120 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Last Updated on CT.gov | May 29, 2026 (May 29, 2026) |
As of July 13, 2026: Clinical trial NCT05016219 is currently recruiting participants. This clinical trial study for mild cognitive impairment is actively seeking new participants at 2 locations across the United States. The study is sponsored by Icahn School of Medicine at Mount Sinai. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05016219 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05016219 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.